Markets:

Overview

News

Currencies

International

Treasuries

Silence Therapeutics Plc - American Depository Share (NQ:SLN)

6.400 +0.210 (+3.39%)

Streaming Delayed Price Updated: 10:23 AM EDT, Mar 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Silence Therapeutics Plc - American Depository Share

< Previous 1 2 3 Next >

Get insights into the top gainers and losers of Thursday's pre-market session. ↗

March 05, 2026

Via Chartmill

Bausch Health’s Slow Rebuild Faces New Scrutiny After Lombard Odier Cuts Its Stake ↗

December 10, 2025

Bausch Health’s valuation suggests potential, but the stake cut shows how far the company still has to go to earn back full investor confidence.

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 21, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 21, 2025

Via Benzinga

Deep Dive Into Silence Therapeutics Stock: Analyst Perspectives (7 Ratings) ↗

March 04, 2025

Via Benzinga

Earnings Scheduled For February 27, 2025 ↗

February 27, 2025

Via Benzinga

Deep Dive Into Silence Therapeutics Stock: Analyst Perspectives (7 Ratings) ↗

February 03, 2025

Via Benzinga

Silence (SLN) Q2 Revenue Drops 71% ↗

August 07, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 03, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 13, 2025

Via Benzinga

These stocks are moving in today's pre-market session ↗

April 01, 2025

Discover the top movers in Tuesday's pre-market session and stay informed about market dynamics.

Via Chartmill

The Analyst Landscape: 6 Takes On Silence Therapeutics ↗

December 10, 2024

Via Benzinga

Analyst Scoreboard: 4 Ratings For Silence Therapeutics ↗

November 15, 2024

Via Benzinga

Analyst Expectations For Silence Therapeutics's Future ↗

August 16, 2024

Via Benzinga

Wall Street's Top 10 Stock Calls This Week - Saturday, Feb. 15 ↗

February 15, 2025

What has Wall Street been buzzing about this week? Here is a look at the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Feb. 10-14, 2025.

Via Talk Markets

Topics Stocks / Equities

This IBM Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗

February 11, 2025

Via Benzinga

Top 3 Health Care Stocks That May Explode In Q4 ↗

December 18, 2024

Via Benzinga

Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst ↗

November 19, 2024

Silence Therapeutics' Phase 2 data shows zerlasiran achieves over 80% Lp(a) reduction in ASCVD patients but faces dosing frequency challenges.

Via Benzinga

Top 3 Health Care Stocks You'll Regret Missing In Q4 ↗

November 19, 2024

Via Benzinga

The Analyst Landscape: 6 Takes On Silence Therapeutics ↗

June 20, 2024

Via Benzinga

What 7 Analyst Ratings Have To Say About Silence Therapeutics ↗

May 17, 2024

Via Benzinga

Beyond The Numbers: 7 Analysts Discuss Silence Therapeutics Stock ↗

April 22, 2024

Via Benzinga

SLN Stock Earnings: Silence Therapeutics Reported Results for Q2 2024 ↗

August 15, 2024

Silence Therapeutics just reported results for the second quarter of 2024.

Via InvestorPlace

The 3 Best Gene Editing Stocks to Buy in August 2024 ↗

August 07, 2024

These are the best gene-editing stocks to buy as the biotechs pursue precision therapies to cure rare diseases.

Via InvestorPlace

Morgan Stanley Predicts Triple-Digit Rally for These 3 Stocks ↗

July 25, 2024

It takes a special set of circumstances for high-growth stocks to double in value in one year but analyst says these three can do it.

Via InvestorPlace

SLN Stock Earnings: Silence Therapeutics Reported Results for Q1 2024 ↗

May 16, 2024

Silence Therapeutics just reported results for the first quarter of 2024.

Via InvestorPlace

3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024 ↗

April 11, 2024

Biotech stocks can offer some of the most explosive, exciting opportunities on the market.That is, if you find the right one.

Via InvestorPlace

7 Biotech Stocks Ready to Ride the Sector’s Resurgence ↗

March 18, 2024

With investors seeking new opportunities with certain segments appearing stretched, biotech stocks offer a viable canvas.

Via InvestorPlace

What 4 Analyst Ratings Have To Say About Silence Therapeutics ↗

March 13, 2024

Via Benzinga

These Analysts Boost Their Forecasts On Silence Therapeutics After Full Year 2023 Results ↗

March 14, 2024

Silence Therapeutics Plc (NASDAQ: SLN) reported a loss for 2023 on Wednesday.

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.